Complement in Pneumococcal Infections with Varying Degrees of Severity

References

• . Alper, C. A., Bloch, K. J. & Rosen, F. C.: Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3. N Engl J Med 288: 601, 1973.
   PubMed Web of Science ®Google Scholar
• . Alper, C. A., Colten, H. R., Rosen, F. C., Robson, A. R., Macnab, G. M. & Gear, J. S. S.: Homozygous deficiency of C3 in a patient with repeated infections. Lancet 2: 1179, 1972.
   PubMed Web of Science ®Google Scholar
• . Coonrod, J. D. & Rylko-Bauer, B.: Complement levels in pneumococcal pneumonia. Infect Immun 18: 14, 1977.
   PubMedGoogle Scholar
• . Dee, T. H., Schiffman, G., Sottile, M. J. & Rytel, M. W.: Immunologic studies in pneumococcal disease. J Lab Clin Med 89: 1198, 1977.
   PubMedGoogle Scholar
• . Dick, G. F.: On the development of proteolytic ferments in the blood during pneumonia. J Infect Dis 10: 383, 1912.
   Google Scholar
• . Fearon, D. T., Ruddy, S., Shur, P. H. & McCabe, W. R.: Activation of the properdin pathway of complement in patients with gram-negative bacteriemia. N Engl J Med 292: 937, 1975.
   PubMed Web of Science ®Google Scholar
• . Fine, D. P.: Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun 12: 772, 1975.
   PubMed Web of Science ®Google Scholar
• . Füst, G., Petrás, G. & Ujhelyi, E.: Activation of the complement system during infections due to gram-negative bacteria. Clin Immunol Immunopathol 5: 293, 1976.
   PubMedGoogle Scholar
• . Hinz, C. F.: Properdin levels in infectious and noninfectious disease. Ann NY Acad Sci 66: 268, 1956.
   Google Scholar
• . Johnson, U., Kamme, C., Laurell, A.-B. & Nilsson, N. J.: C1 subcomponents in acute pneumococcal otitis media in children. Acta Pathol Microbiol Scand [C] 85: 10, 1977.
   PubMedGoogle Scholar
• . Johnson, U.: The role of C1s, C1r and properdin in the initiation of the C3b-dependent feedback mechanism of the complement system. Acta Pathol Microbiol Scand [C] 86: 73, 1978.
   PubMedGoogle Scholar
• . Johnston, R. B. Jr., Klemperer, M. R., Alper, C. A. & Rosen, F. S.: The enchancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med 129: 1275, 1969.
   PubMed Web of Science ®Google Scholar
• . Laurell, A.-B., Mårtensson, U. & Sjöholm, A.: C1 subcomponent complexes in normal and pathological sera studied by crossed immunoelectrophoresis. Acta Pathol Microbiol Scand [C] 84: 455, 1976.
   Google Scholar
• . Laurell, A.-B., Mårtensson, U. & Sjöholm, A.: Formation of complexes composed of Cīr-Cīs-Cī inactivator in human serum of activation of C1. Acta Pathol Microbiol Scand [C] 86: 299, 1978.
   Google Scholar
• . Laurell, A.-B., Mårtensson, U. & Sjöholm, A.: The development of simple tests for C1q, C1r, C1s and C2, and the determination of properdin. In: Clinical aspects of the complement system (ed. W. Opferkuch and K. Rother). Georg Thieme Publishers, Stuttgart 1979.
   Google Scholar
• . Laurell, A.-B., Mårtensson, U. & Sjöholm, A.: Quantitation of Cīr-Cīs-Cī inactivator complexes by electroimmunoassay. Acta Pathol Microbiol Scand [C] 87: 7 9, 1979.
   Google Scholar
• . Laurell, C.-B.: Electroimmunoassay. Scand J Clin Lab Invest 29, Suppl. 124: 21, 1972.
   Web of Science ®Google Scholar
• . Loos, M., Wellek, B., Thesen, R. & Opferkuch, W.: Antibody-independent interaction of the first component of complement with gram-negative bacteria. Infect Immun 22: 5, 1978.
   PubMedGoogle Scholar
• . Mak, L. W., Lachmann, P. J. & Majewski, J.: The activation of the C3 feedback cycle with human complement components. I. Through the classical pathway. Clin Exp Immunol 30: 200, 1977.
   PubMedGoogle Scholar
• . McCabe, W. R.: Serum complement levels in bacteriemia due to gram-negative organisms. N Engl J Med 288: 21, 1973.
   PubMed Web of Science ®Google Scholar
• . Prellner, K.: Complement activation by pneumococci associated with acute otitis media. Acta Pathol Microbiol Scand [C] 87: 213, 1979.
   Google Scholar
• . Prellner, K.: Bacteria associated with acute otitis media have high C1q binding capacity. Acta Pathol Microbiol Scand [C] 88: 187, 1980.
   PubMedGoogle Scholar
• . Reed, W. P., Davidson, M. S. & Williams, R. C. Jr: Complement system in pneumococcal infections. Infect Immun 13: 1120, 1976.
   PubMedGoogle Scholar
• . Rytel, M. W., Dee, T. H., Ferstenfeld, J. E. & Hensley, G. T.: Possible pathogenic role of capsular antigens in fulminant pneumococcal disease with disseminated intravascular coagulation (DIC). Am J Med 57: 889, 1974.
   PubMed Web of Science ®Google Scholar
• . Schutte, M., Di Camelli, R., Murphy, P., Sadove, M. & Gewurz, H.: C3 proactivator (C3PA) as an acute phase reactant. Clin Exp Immunol 18: 251, 1974.
   PubMed Web of Science ®Google Scholar
• . Shin, H. S., Smith, M. R. & Wood, W. B.: Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5. J Exp Med 130: 1229, 1969.
   PubMed Web of Science ®Google Scholar
• . Sjöholm, A. G.: Complement components in normal serum and plasma quantitated by electroimmunoassay. Scand J Immunol 4: 25, 1975.
   PubMed Web of Science ®Google Scholar
• . Stephens, C. G., Williams, R. C. Jr & Reed, W. P.: Classical and alternative complement pathway activation by pneumococci. Infect Immun 17: 296, 1977.
   PubMed Web of Science ®Google Scholar
• . Whicher, J. T.: The value of complement assays in clinical chemistry. Clin Chem 24: 7, 1978.
   PubMedGoogle Scholar
• . Whitaker, A. N.: Infection and the spleen: Association between hyposplenism, pneumococcal sepsis and disseminated intravascular coagulation. Med J Aust 1: 1213, 1969.
   PubMed Web of Science ®Google Scholar
• . Winkelstein, J. A., Smith, M. R. & Shin, H. S.: The role of C3 as an opsonin in the early stages of infection. Proc Soc Exp Biol Med 149: 397, 1975.
   PubMed Web of Science ®Google Scholar
• . Winkelstein, J. A. & Tomasz, A.: Activation of the alternative pathway by pneumococcal cell walls. J Immunol 118: 451, 1977.
   PubMedGoogle Scholar
• . Winkelstein, J. A. & Tomasz, A.: Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol 120: 174, 1978.
   PubMed Web of Science ®Google Scholar